Acknowledgement
We would like to express our gratitude to the staff of the Center for FMD Vaccine Research at the Animal and Plant Quarantine Agency for the management of FMD BL-3 and ABSL-3 facility. We thank 'SEPPIC, France' and 'INTERCARE Co. Ltd, Korea' for supporting various adjuvants.
References
- Belsham GJ. Distinctive features of foot-and-mouth disease virus, a member of the picornavirus family; aspects of virus protein synthesis, protein processing and structure. Prog Biophys Mol Biol. 1993;60(3):241-60. https://doi.org/10.1016/0079-6107(93)90016-D
- Knowles NJ, Samuel AR. Molecular epidemiology of foot-and-mouth disease virus. Virus Res. 2003;91(1):65-80. https://doi.org/10.1016/S0168-1702(02)00260-5
- Alexandersen S, Donaldson AI. Further studies to quantify the dose of natural aerosols of foot-and-mouth disease virus for pigs. Epidemiol Infect. 2002;128(2):313-23. https://doi.org/10.1017/s0950268801006501
- Alexandersen S, Zhang Z, Donaldson AI, Garland AJ. The pathogenesis and diagnosis of foot-and-mouth disease. J Comp Pathol. 2003;129(1):1-36. https://doi.org/10.1016/S0021-9975(03)00041-0
- Donaldson AI, Alexandersen S. Predicting the spread of foot and mouth disease by airborne virus. Rev Sci Tech. 2002;21(3):569-75. https://doi.org/10.20506/rst.21.3.1362
- Mort M, Convey I, Baxter J, Bailey C. Animal disease and human trauma: the psychosocial implications of the 2001 UK foot and mouth disease disaster. J Appl Anim Welf Sci. 2008;11(2):133-48. https://doi.org/10.1080/10888700801925984
- Paarlberg PL, Lee JG, Seitzinger AH. Potential revenue impact of an outbreak of foot-and-mouth disease in the United States. J Am Vet Med Assoc. 2002;220(7):988-92. https://doi.org/10.2460/javma.2002.220.988
- Golde WT, Pacheco JM, Duque H, Doel T, Penfold B, Ferman GS, et al. Vaccination against foot-andmouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: use in emergency outbreak response. Vaccine. 2005;23(50):5775-82. https://doi.org/10.1016/j.vaccine.2005.07.043
- Ibrahim EE, Gamal WM, Hassan AI, Mahdy SE, Hegazy AZ, Abdel-Atty MM. Comparative study on the immunopotentiator effect of ISA 201, ISA 61, ISA 50, ISA 206 used in trivalent foot and mouth disease vaccine. Pak J Life Soc Sci. 2016;14:178-82.
- Ko EY, Jung S, Jeong HK, Han JH, Son JH. Effect of Foot-and-mouth disease vaccination location and injection device on the incidence of site lesions in pork. Korean J Food Sci Anim Resour. 2018;38(3):498-505. https://doi.org/10.5851/KOSFA.2018.38.3.498
- Patil PK, Sajjanar CM, Natarajan C, Bayry J. Neutralizing antibody responses to foot-and-mouth disease quadrivalent (type O, A, C and Asia 1) vaccines in growing calves with pre-existing maternal antibodies. Vet Microbiol. 2014;169(3-4):233-5. https://doi.org/10.1016/j.vetmic.2014.01.005
- Cao Y. Adjuvants for foot-and-mouth disease virus vaccines: recent progress. Expert Rev Vaccines. 2014;13(11):1377-85. https://doi.org/10.1586/14760584.2014.963562
- Park ME, You SH, Lee SY, Lee KN, Ko MK, Choi JH, et al. Immune responses in pigs and cattle vaccinated with half-volume foot-and-mouth disease vaccine. J Vet Sci. 2017;18(Suppl 1):323-31. https://doi.org/10.4142/jvs.2017.18.S1.323
- Li D, Zhou C, She D, Li P, Sun P, Bai X, et al. The comparison of the efficacy of swine FMD vaccine emulsified with oil adjuvant of ISA 201 VG or ISA 206 VG. J Biosci Med. 2013;1:22-5. https://doi.org/10.4236/jbm.2013.13005
- Ren J, Yang L, Xu H, Zhang Y, Wan M, Liu G, et al. CpG oligodeoxynucleotide and montanide ISA 206 adjuvant combination augments the immune responses of a recombinant FMDV vaccine in cattle. Vaccine. 2011;29(45):7960-5. https://doi.org/10.1016/j.vaccine.2011.08.072
- Burakova Y, Madera R, McVey S, Schlup JR, Shi J. Adjuvants for Animal Vaccines. Viral Immunol. 2018;31(1):11-22. https://doi.org/10.1089/vim.2017.0049
- Choi SH, Park SI. Economic burden of foot-and-mouth disease vaccination-induced injection site lesions in slaughtered pigs and its cause relationship. J Prev Med Public Health. 2015;39(4):153-6.
- Dykman LA, Staroverov SA, Mezhenny PV, Fomin AS, Kozlov SV, Volkov AA, et al. Use of a synthetic foot-and-mouth disease virus peptide conjugated to gold nanoparticles for enhancing immunological response. Gold Bull. 2015;48(1-2):93-101. https://doi.org/10.1007/s13404-015-0165-1
- Choi JH, Ko MK, Shin SH, You SH, Jo HE, Jo H, et al. Improved foot-and-mouth disease vaccine, O TWN-R, protects pigs against SEA topotype virus occurred in South Korea. Vet Microbiol. 2019;236:108374. https://doi.org/10.1016/j.vetmic.2019.07.026